Patients with elevated fasting insulin levels, PCOS, or metabolic syndrome may derive the greatest benefit, as their insulin dysfunction represents a primary driver of weight accumulation
ADJUNCT TWO was a 26-week, double-blind, parallel-group trial with 835 people randomised 3:1 to liraglutide or placebo (Ahrn et al, 2016)
Department of Justice for investigation over potential violations of the federal Food, Drug, and Cosmetic Act
FAQS Weve compiled a list of frequently asked questions about our services, treatments, and policies
It seems GLP-1s have a potential role in treating depression through the gut-brain axis
How, exactly, are GLP-1 patches supposed to work